ARTA: Adaptive Mixed-Resolution Token Allocation for Efficient Dense Feature Extraction

We present ARTA, a mixed-resolution coarse-to-fine vision transformer for efficient dense feature extraction. Unlike models that begin with dense high-resolution (fine) tokens, ARTA starts with low-resolution (coarse) tokens and uses a lightweight allocator to predict which regions require more fine tokens. The allocator iteratively predicts a semantic (class) boundary score and allocates additional tokens to patches above a low threshold, concentrating token density near boundaries while maintaining high sensitivity to weak boundary evidence. This targeted allocation encourages tokens to represent a single semantic class rather than a mixture of classes. Mixed-resolution attention enables interaction between coarse and fine tokens, focusing computation on semantically complex areas while avoiding redundant processing in homogeneous regions. Experiments demonstrate that ARTA achieves state-of-the-art results on ADE20K and COCO-Stuff with substantially fewer FLOPs, and delivers competitive performance on Cityscapes at markedly lower compute. For example, ARTA-Base attains 54.6 mIoU on ADE20K in the ~100M-parameter class while using fewer FLOPs and less memory than comparable backbones.

Optimizing Gene-Based Testing for Antibiotic Resistance Prediction

Antibiotic Resistance (AR) is a critical global health challenge that necessitates the development of cost-effective, efficient, and accurate diagnostic tools. Given the genetic basis of AR, techniques such as Polymerase Chain Reaction (PCR) that target specific resistance genes offer a promising approach for predictive diagnostics using a limited set of key genes. This study introduces GenoARM, a novel framework that integrates reinforcement learning (RL) with transformer-based models to optimize the selection of PCR gene tests and improve AR predictions, leveraging observed metadata for improved accuracy. In our evaluation, we developed several high-performing baselines and compared them using publicly available datasets derived from real-world bacterial samples representing multiple clinically relevant pathogens. The results show that all evaluated methods achieve strong and reliable performance when metadata is not utilized. When metadata is introduced and the number of selected genes increases, GenoARM demonstrates superior performance due to its capacity to approximate rewards for unseen and sparse combinations. Overall, our framework represents a major advancement in optimizing diagnostic tools for AR in clinical settings.